Sonic Healthcare : Appendix 3B Opens in a new Window

Appendix 3B

New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement,

application for quotation of additional securities

and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

SONIC HEALTHCARE LIMITED

ABN

24 004 196 909

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1. +Class of +securities issued or to be issued
2. Number of +securities issued or to be issued (if known) or maximum number which may be issued

Ordinary shares

352,000

3	Principal	terms	of	the	Fully paid ordinary shares
	+securities	(e.g. if	options,
	exercise price and expiry date; if
	partly	paid	+securities,	the
	amount	outstanding	and	due
	dates	for	payment;	if
	+convertible	securities,	the
	conversion price and dates for
	conversion)

+ See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 1

Appendix 3B

New issue announcement

1. Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?
   If the additional +securities do not rank equally, please state:
2. • the date from which they do
   • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
   • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
3. Issue price or consideration

6 Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

Yes

• 70,000 shares issued at $29.52 per share on the exercise of options with an exercise price of $18.84 per option.
• 82,500 shares issued at $29.52 per share on the exercise of options with an exercise price of $19.78 per option
• 15,000 shares issued at $29.52 per share on the exercise of options with an exercise price of $21.62 per option
• 56,500 shares issued on the exercise of options with an exercise price of $18.84 per option.
• 83,000 shares issued on the exercise of options with an exercise price of $19.78 per option.
• 25,000 shares issued on the exercise of options with an exercise price of $21.62 per option.
• 20,000 shares issued on the exercise of options with an exercise price of $22.02 per option.

Exercise of options

+ See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

Appendix 3B

New issue announcement

6a Is the entity an +eligible entity No that has obtained security holder approval under rule 7.1A?

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

6b	The date	the security	holder	N/A
	resolution under rule 7.1A was
	passed
6c	Number	of +securities	issued
N/A
	without	security	holder
	approval under rule 7.1
6d	Number	of +securities	issued
N/A
	with security holder approval
	under rule 7.1A
6e	Number	of +securities	issued
N/A
	with security holder approval
	under rule 7.3, or another
	specific security holder approval
	(specify date of meeting)

6f Number of +securities issued under an exception in rule 7.2

6g If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

N/A

N/A

6h	If +securities were issued under	N/A
	rule	7.1A	for	non‐cash
	consideration, state	date	on
	which		valuation		of
	consideration	was released	to
	ASX Market Announcements
6i	Calculate the entity's remaining
N/A
	issue capacity under rule 7.1 and
	rule 7.1A - complete Annexure 1
	and release to ASX Market
	Announcements

+ See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 3

Appendix 3B

New issue announcement

7	+Issue dates	4 September 2019
	Note: The issue date may be prescribed by
	ASX (refer to the definition of issue date in
	rule 19.12). For example, the issue date for a
	pro rata entitlement issue must comply with
	the applicable timetable in Appendix 7A.
	Cross reference: item 33 of Appendix 3B.

+ See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

							Appendix 3B
						New issue announcement
8	Number	and +class	of	all	Number		+Class
474,433,904		Ordinary
	+securities	quoted	on	ASX
	(including the +securities in
	section 2 if applicable)

9 Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

Number	+Class
	Options Expiring on:
250,069	27.11.2019 @ $17.32
31,500	30.11.2019 @ $18.84
552,500	20.08.2020 @ $18.49
356,641	20.11.2020 @ $19.41
1,432,833	11.10.2020 @ $19.78
760,000	17.09.2021 @ $21.62
180,000	17.09.2021 @ $22.02
671,089	17.11.2021 @ $21.62
950,000	05.05.2022 @ $23.34
675,145	22.11.2022 @ $21.64
667,787	21.11.2023 @ $21.69
2,000,000	14.10.2023 @ $21.83
980,000	21.12.2023 @ $24.30
	Performance Rights
	Expiring on:
87,843	17.11.2021
87,762	22.11.2022
87,560	21.11.2023

10	Dividend policy (in the case of a	Same as existing
	trust, distribution policy) on the
	increased capital (interests)

Part 2 - Pro rata issue

11 Is security holder approval N/A required?

12	Is the issue renounceable or non‐	N/A
	renounceable?

13 Ratio in which the +securities N/A will be offered

14	+Class of +securities to which the	N/A
	offer relates

+ See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 5